Difficulty: Medium
Average Score: 85%
Quiz
Myasthenia gravis is an autoimmune disease of the neuromuscular junction characterized by the fluctuating weakness of certain skeletal muscle groups. The use of intravenous immune globulin is for which response?
Correct answer
C
Rationale
Myasthenia gravis is caused by antibodies attacking acetylcholine receptors at the neuromuscular junction, leading to muscle weakness. Intravenous immune globulin (IVIG) contains antibodies that can help remove the harmful antibodies produced by the autoimmune response in myasthenia gravis. This treatment approach aims to reduce the levels of the pathogenic antibodies and alleviate symptoms by blocking their effects on acetylcholine receptors. Therefore, option C, 'Removes the antibodies produced by the autoimmune response,' is the correct response as IVIG helps to neutralize the autoantibodies responsible for the condition.